Teladoc Health, Inc.

NYSE:TDOC Rapport sur les actions

Capitalisation boursière : US$1.8b

Teladoc Health Croissance future

Future contrôle des critères 0/6

Teladoc Health devrait augmenter ses bénéfices et son chiffre d'affaires de 81.6% et de 0.7% par an respectivement. Le BPA devrait croître de de 86.2% par an. Le rendement des capitaux propres devrait être -10.9% dans 3 ans.

Informations clés

81.6%

Taux de croissance des bénéfices

86.2%

Taux de croissance du BPA

Healthcare Services croissance des bénéfices31.0%
Taux de croissance des recettes0.7%
Rendement futur des capitaux propres-10.9%
Couverture par les analystes

Good

Dernière mise à jour18 Nov 2024

Mises à jour récentes de la croissance future

Teladoc Health, Inc. (NYSE:TDOC) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 02
Teladoc Health, Inc. (NYSE:TDOC) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Recent updates

Teladoc Health, Inc. (NYSE:TDOC) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 02
Teladoc Health, Inc. (NYSE:TDOC) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Is Teladoc Health (NYSE:TDOC) A Risky Investment?

Oct 23
Is Teladoc Health (NYSE:TDOC) A Risky Investment?

Teladoc: Double-Digit FCF Yield, Possible BetterHelp Transition

Oct 13

Teladoc Health, Inc. (NYSE:TDOC) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Sep 18
Teladoc Health, Inc. (NYSE:TDOC) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Teladoc Health: Some Negative Things, But One Aspect That Makes Me Feel Positive

Sep 15

Teladoc: Prospects Are Ready For Better Health

Sep 04

Teladoc Post Q2 Earnings: Stick A Fork In This Stock - It's Nearly Done (For)

Aug 01

Teladoc's Vital Signs: Why 5x FCF Means Stable Health (Rating Upgrade)

Jul 22

Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors

Jul 17
Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors

Teladoc Health: Weight Loss Management Could Help

Jul 01

Would Teladoc Health (NYSE:TDOC) Be Better Off With Less Debt?

Jun 04
Would Teladoc Health (NYSE:TDOC) Be Better Off With Less Debt?

Teladoc: Stock Likely To Be Range Bound Until Guidance Is Revised Upwards

May 31

Teladoc: Huge Execution Problem

Apr 27

Teladoc: Improving Business Trends (Rating Upgrade)

Apr 17

Teladoc: Management Has A Lot To Prove To Gain Investor Confidence

Mar 25

Teladoc Health, Inc.'s (NYSE:TDOC) 25% Dip In Price Shows Sentiment Is Matching Revenues

Mar 10
Teladoc Health, Inc.'s (NYSE:TDOC) 25% Dip In Price Shows Sentiment Is Matching Revenues

Teladoc Health: Another Bad Quarter, Another Wave Of Capitulation

Feb 21

Teladoc Health: Weight Management Rescue

Jan 21

Teladoc Health (NYSE:TDOC) Is Carrying A Fair Bit Of Debt

Jan 15
Teladoc Health (NYSE:TDOC) Is Carrying A Fair Bit Of Debt

When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Dec 12
When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Teladoc Q3: Getting Stronger (Rating Upgrade)

Nov 29

Teladoc Health, Inc.'s (NYSE:TDOC) Intrinsic Value Is Potentially 78% Above Its Share Price

Nov 22
Teladoc Health, Inc.'s (NYSE:TDOC) Intrinsic Value Is Potentially 78% Above Its Share Price

Teladoc Was Obliterated

Oct 25

Is Teladoc Health (NYSE:TDOC) A Risky Investment?

Oct 11
Is Teladoc Health (NYSE:TDOC) A Risky Investment?

Teladoc: Broken Growth Story Deteriorates Further (Rating Downgrade)

Oct 02

Teladoc Stock: A Hold Amid New Covid Wave

Sep 14

Teladoc's Technical Decline Hints At A Buying Opportunity

Aug 28

Is There An Opportunity With Teladoc Health, Inc.'s (NYSE:TDOC) 44% Undervaluation?

Aug 18
Is There An Opportunity With Teladoc Health, Inc.'s (NYSE:TDOC) 44% Undervaluation?

Buy Teladoc: AI Will Likely Spur Healthcare Deflation

Aug 16

Teladoc's Future: Virtual Healthcare, AI, And Valuation

Jul 28

Teladoc And Microsoft's Expanded Strategic Partnership Is A Powerful AI Combo

Jul 21

The Big Trends: New Frontiers in Healthcare

Jul 13
The Big Trends: New Frontiers in Healthcare

When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Jul 10
When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Teladoc Health: Likely To Remain Out Of Favor

Jun 26

Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors

Jun 25
Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors

Here's Why Teladoc Health (NYSE:TDOC) Can Afford Some Debt

May 25
Here's Why Teladoc Health (NYSE:TDOC) Can Afford Some Debt

Teladoc: BetterHelp Segment Margins Are Key

May 23

Are Investors Undervaluing Teladoc Health, Inc. (NYSE:TDOC) By 20%?

May 06
Are Investors Undervaluing Teladoc Health, Inc. (NYSE:TDOC) By 20%?

Is It Too Late To Consider Buying Teladoc Health, Inc. (NYSE:TDOC)?

Mar 10
Is It Too Late To Consider Buying Teladoc Health, Inc. (NYSE:TDOC)?

Teladoc Health Non-GAAP EPS of -$0.23 misses by $0.04, revenue of $637.7M beats by $4.33M

Feb 22

Prévisions de croissance des bénéfices et des revenus

NYSE:TDOC - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20262,592-14624137819
12/31/20252,543-15421436325
12/31/20242,568-98817631425
9/30/20242,590-982207338N/A
6/30/20242,609-1,006196333N/A
3/31/20242,619-233200346N/A
12/31/20232,602-220194350N/A
9/30/20232,580-4,002112285N/A
6/30/20232,531-4,01864243N/A
3/31/20232,471-7,05447234N/A
12/31/20222,407-13,66017189N/A
9/30/20222,323-9,86065207N/A
6/30/20222,234-9,871107221N/A
3/31/20222,144-6,90499180N/A
12/31/20212,033-429130194N/A
9/30/20211,862-812-54-4N/A
6/30/20211,629-763-92-49N/A
3/31/20211,367-655-102-65N/A
12/31/20201,094-485-80-54N/A
9/30/2020867-1105980N/A
6/30/2020716-954661N/A
3/31/2020606-981931N/A
12/31/2019553-991930N/A
9/30/2019520-105414N/A
6/30/2019493-108211N/A
3/31/2019457-103-81N/A
12/31/2018418-97-13-5N/A
9/30/2018372-117-22-15N/A
6/30/2018330-125N/A-37N/A
3/31/2018280-115N/A-36N/A
12/31/2017233-107N/A-34N/A
9/30/2017194-77N/A-35N/A
6/30/2017157-75N/A-38N/A
3/31/2017139-75N/A-47N/A
12/31/2016123-74N/A-52N/A
9/30/2016108-75N/A-57N/A
6/30/201696-58N/A-59N/A
3/31/201688-61N/A-54N/A
12/31/201577-58N/A-47N/A
9/30/201568-50N/A-39N/A
6/30/201559-42N/A-24N/A
3/31/201551-29N/A-19N/A
12/31/201444-20N/A-11N/A
12/31/201320-10N/A-6N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: TDOC devrait rester non rentable au cours des 3 prochaines années.

Bénéfices vs marché: TDOC devrait rester non rentable au cours des 3 prochaines années.

Croissance élevée des bénéfices: TDOC devrait rester non rentable au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de TDOC ( 0.7% par an) devrait croître plus lentement que le marché de US ( 8.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de TDOC ( 0.7% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: TDOC devrait être non rentable dans 3 ans.

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y